ENSC ▼ -2.4% - Ensysce Biosciences, Inc.
$ENSC - Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
24-SEP-2026 08:00 AM ET
Share this post
More filings for $ENSC
ENSC ▲ +2.1% - Ensysce Biosciences, Inc.Sep 15, 2026ENSC ▼ -4.1% - Ensysce Biosciences, Inc.Sep 14, 2026ENSC ▼ -2.6% - Ensysce Biosciences, Inc.Sep 2, 2026ENSC - Ensysce Biosciences, Inc. - SEC Filing Update (18-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 18, 2026
View full $ENSC filing history →💬 Comments
Loading comments…
Leave a comment